--- title: "PRCT PROCEPT BioRobotics" canonical: "https://supercyclehq.com/stock/procept-biorobotics" type: "stock" dataAsOf: "2026-11-06" ticker: "PRCT" license: "Free to use and quote with attribution to supercyclehq.com. Do not redistribute as a dataset." disclaimer: "Informational only, not investment advice. The AI Exposure Score is Supercycle's editorial opinion. Agent portfolios are simulated paper portfolios run by AI." --- # PROCEPT BioRobotics (PRCT) PROCEPT BioRobotics is a surgical robotics company focused on urology. ## AI Exposure Score **55/100, Strategic.** PROCEPT sells the AquaBeam surgical robot plus per procedure handpieces for BPH treatment, with AI assisted planning and real time tissue mapping. It is a robotics adoption story at heart, hinging on surgeons converting procedures to its robot rather than on AI demand broadly. ## Quote | Field | Value | | --- | --- | | Price (EOD close) | $20.62 | | Change 1d | +1.73% | | Change 7d | +7.40% | | Change 30d | +15.20% | | Change 1y | -35.40% | | 52-week high | $36.10 | | 52-week low | $16.69 | | Market cap | $1.2B | | P/E | n/a | | EPS | $-2.02 | | Next earnings | 2026-11-04 | Quote as of 2026-11-06. ## Company | Field | Value | | --- | --- | | Exchange | NASDAQ | | Sector | Healthcare | | Headquarters | Redwood City, California | | CEO | Larry L. Wood | | Employees | 888 | | Website | https://www.procept-biorobotics.com | | Buildout layers | [Robotics & Automation](https://supercyclehq.com/category/robotics), [AI Healthcare](https://supercyclehq.com/category/ai-healthcare) | ## What the company does PROCEPT BioRobotics is a surgical robotics company focused on urology. Its AquaBeam Robotic System treats benign prostatic hyperplasia, an enlarged prostate, using a robot-guided waterjet. Revenue comes from selling the robot to hospitals plus the handpieces consumed in every procedure. AI supports the procedure itself: AI surgical planning maps each treatment before it starts, and real-time tissue mapping guides the waterjet during surgery, keeping removal precise and consistent across surgeons. Founded in 2009 and headquartered in Redwood City, California, PROCEPT trades on the NASDAQ and employs about 890 people under CEO Larry L. Wood. ## Role in the AI buildout PROCEPT sits in the Robotics & Automation and AI Healthcare layers, putting AI directly into the operating room. Its planning and tissue mapping software is what makes the AquaBeam robot consistent from surgeon to surgeon, so AI is genuinely embedded in the product. The investment story, though, is robotics adoption: it depends on surgeons converting procedures to its system rather than on AI demand broadly. Supercycle scores its AI exposure at 55 out of 100. ## Recent news - [PROCEPT BioRobotics (PRCT) Stock Dropped, So What Is Driving Attention Now?](https://finance.yahoo.com/markets/stocks/articles/procept-biorobotics-prct-stock-dropped-181943969.html?.tsrc=rss) (source, 2026-11-06) - [PROCEPT BioRobotics Corp (PRCT) (Q3 2026) Earnings Call Highlights: Revenue Grows 18% as Hydros ...](https://finance.yahoo.com/news/procept-biorobotics-corp-prct-q3-071427160.html?.tsrc=rss) (source, 2026-11-05) - [PROCEPT BioRobotics Q3 Earnings Call Highlights](https://www.marketbeat.com/instant-alerts/transcript-procept-biorobotics-q3-earnings-call-highlights-2026-11-04/?utm_source=yahoofinance&utm_medium=yahoofinance&.tsrc=rss) (source, 2026-11-05) - [PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Lags Revenue Estimates](https://finance.yahoo.com/markets/stocks/articles/procept-biorobotics-corporation-prct-reports-234508330.html?.tsrc=rss) (source, 2026-11-04) - [PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance](https://finance.yahoo.com/healthcare/articles/procept-biorobotics-reports-third-quarter-210500438.html?.tsrc=rss) (source, 2026-11-04) ## FAQ ### What does PROCEPT BioRobotics do? PROCEPT makes the AquaBeam Robotic System, a surgical robot that treats enlarged prostate using a guided waterjet. It earns revenue from robot sales to hospitals and from handpieces used in every procedure. ### How is PROCEPT exposed to AI? Through embodied AI in surgery. AI-assisted planning and real-time tissue mapping guide every AquaBeam procedure, though the thesis rests on surgical adoption rather than AI demand broadly. Supercycle rates its AI Exposure Score at 55 out of 100. ### What are PROCEPT's main products? The AquaBeam Robotic System for minimally invasive prostate procedures, AI surgical planning software that maps each treatment, and real-time tissue mapping that guides the waterjet during surgery. ### Is PRCT a pure play AI stock? No. It is a surgical robotics adoption story where AI makes the robot precise and repeatable. An AI Exposure Score of 55 out of 100 reflects strong AI content inside a device-driven thesis. ### Where is PROCEPT based and who leads it? PROCEPT BioRobotics is headquartered in Redwood City, California, and led by CEO Larry L. Wood. Founded in 2009, the company employs about 890 people and trades on the NASDAQ. --- Source: https://supercyclehq.com/stock/procept-biorobotics. Data as of 2026-11-06. Prices are end-of-day closes, never live. Informational only, not investment advice. The AI Exposure Score is Supercycle's editorial opinion. Agent portfolios are simulated paper portfolios run by AI. Free to use and quote with attribution to supercyclehq.com. Do not redistribute as a dataset.